Omega Healthcare Investors (NYSE:OHI) is scheduled to release its earnings data after the market closes on Tuesday, February 6th. Analysts expect Omega Healthcare Investors to post earnings of $0.49 per share for the quarter.

Shares of Omega Healthcare Investors (OHI) opened at $26.38 on Monday. The firm has a market capitalization of $5,200.00, a P/E ratio of 34.71, a PEG ratio of 2.72 and a beta of 0.41. Omega Healthcare Investors has a 1 year low of $25.80 and a 1 year high of $35.14. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.40 and a quick ratio of 3.40.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Wednesday, January 31st will be given a $0.66 dividend. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.65. This represents a $2.64 dividend on an annualized basis and a dividend yield of 10.01%. The ex-dividend date of this dividend is Tuesday, January 30th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 347.37%.

A number of brokerages have recently weighed in on OHI. Cantor Fitzgerald began coverage on Omega Healthcare Investors in a research report on Wednesday, December 20th. They issued an “overweight” rating and a $34.00 price objective on the stock. Jefferies Group restated an “underperform” rating on shares of Omega Healthcare Investors in a research note on Thursday, December 21st. ValuEngine upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research note on Friday, December 15th. SunTrust Banks set a $28.00 target price on Omega Healthcare Investors and gave the company a “hold” rating in a research note on Monday, January 22nd. Finally, Vetr cut Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 target price for the company. in a research note on Thursday, October 19th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $31.85.

In related news, Director Bernard J. Korman acquired 100,000 shares of the stock in a transaction on Friday, December 22nd. The stock was acquired at an average price of $26.89 per share, for a total transaction of $2,689,000.00. Following the completion of the purchase, the director now owns 896,895 shares of the company’s stock, valued at $24,117,506.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.54% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Earnings History for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with's FREE daily email newsletter.